Lishan Peng

A single-cell atlas reveals immune heterogeneity in anti-PD-1-treated non-small cell lung cancer

Zedao Liu, Zhenlin Yang, Junqi Wu et al. · Cell · 2025 · 105 citations · Full text

Medicine, Bioinformatics, Oncology +14

Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104)

Chao Zhang, Yuxuan Sun, Dingcheng Yi et al. · Cell Reports Medicine · 2024 · 35 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Radiomics-Based Support Vector Machine Distinguishes Molecular Events Driving the Progression of Lung Adenocarcinoma

Hongji Li, Zhen‐Bin Qiu, Meng-Min Wang et al. · Journal of Thoracic Oncology · 2024 · 30 citations · Full text

Medicine, Bioinformatics, Oncology +12

Advanced oxidation protein products induce G1 phase arrest in intestinal epithelial cells via a RAGE/CD36-JNK-p27kip1 mediated pathway

Jie Shi, Shibo Sun, Yan Liao et al. · Redox Biology · 2019 · 26 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

PD-1 Upregulation Is Associated with Exhaustion of Regulatory T Cells and Reflects Immune Activation in HIV-1-Infected Individuals

Jian Xiao, Lifeng Zhang, Yuan Dong et al. · AIDS Research and Human Retroviruses · 2019 · 13 citations

Life Sciences, Immunology, Infectious Diseases +17